Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. - Wikidata - awgldk - TriplyDB

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

http://www.wikidata.org/entity/Q33341180

about

Updates of mTOR inhibitors Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy Updated overview of current biomarkers in head and neck carcinoma The determinants of head and neck cancer: Unmasking the PI3K pathway mutations The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study.Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.The complexes of mammalian target of rapamycin.Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics.Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma.Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.Distinct DNA methylation patterns of cognitive impairment and trisomy 21 in Down syndrome.Glucose deprivation in tuberous sclerosis complex-related tumors.Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6 Gene expression profiling of oral squamous cell carcinoma by differential display rt-PCR and identification of tumor biomarkers.Molecular Docking studies of FKBP12-mTOR inhibitors using binding predictions Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.Regulation of PI 3-K, PTEN, p53, and mTOR in Malignant and Benign Tumors Deficient in Tuberin A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer.Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation Analysis of whole genomic expression profiles and screening of the key signaling pathways associated with pancreatic cancer Expression of phosphorylated mTOR and its regulatory protein is related to biological behaviors of ameloblastoma.Possibility of the use of public microarray database for identifying significant genes associated with oral squamous cell carcinoma Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma.eIF4F suppression in breast cancer affects maintenance and progression The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling.Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.A four-gene signature predicts survival in clear-cell renal-cell carcinoma Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung.The targets of curcumin.Current development of the second generation of mTOR inhibitors as anticancer agents.Monascus purpureus-fermented products and oral cancer: a review.Role of DNA methylation in head and neck cancer.TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO).mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer.

P2860

Q24607170-E74F27CE-2A79-4E84-BB83-325E9B3CE382 Q24628724-7DE00B9E-B61E-41AF-900A-E74700A4C99F Q26750659-B2BB2EA4-062D-46B6-A7A9-0EE60876EA5B Q30365726-54CA9825-BF2C-413F-8900-325E39122DB0 Q33437313-D1D03B8E-4739-43C7-9D44-9CEA6CE8D4C6 Q33508931-6C7840DE-EE92-4B65-9A02-93C7863C8735 Q33604076-6419CF92-20F8-4044-8CA9-04F1D1F28202 Q33698618-33AD0102-B3D6-4C88-91F6-88316CE3AFCF Q33820845-A6D0E575-E41E-49C2-8D25-50D2F60E525D Q33831975-0CF391F0-F19F-4637-849F-8B50DD55B794 Q34116818-8ED86D9F-DE72-4BB5-A117-AF97AE714DF2 Q34312760-827E7AF6-D5F2-4B44-88EF-0BDE2E061C7E Q34614246-A8751AAC-9F43-4156-96DB-F9E5D152751F Q34724225-F40A275D-24ED-4FBE-A132-42FA57FCA043 Q35076922-C92D84E8-DBA7-447D-BB71-C541DA68F8D3 Q35560024-E1DB440D-C119-47D4-9D72-7DC10FA72CED Q35625440-AFC3CB41-F0F7-4177-9628-6C1F527A2C38 Q35628278-3E6BC0F2-9854-402D-B461-01C5A14E1277 Q35881144-2BA11FA7-32D3-4453-8417-FA478ABA10D7 Q35994228-51381A30-BCD6-468A-BE21-72F237BBEA93 Q36047109-77FD44F5-6E35-4ABB-B39C-373AFF09DCE2 Q36152896-4F4B0D74-9F6C-4465-90B7-393BAA32101A Q36174374-6E260762-C569-4E7A-97F7-32872E65C69B Q36196775-E511BC90-44F1-4FCE-A47F-9B4034AB07DE Q36224947-5BB9EC90-5DB9-43CD-A28F-0F2013E2DE89 Q36330529-0E6EFDE9-7FEB-4793-A457-D614857CE3E1 Q36524668-F799C197-46EA-49CA-9E92-FA07E112847B Q36892399-51C2E608-62C6-40D9-B707-4DD416BA7FE4 Q37197352-B4C0664C-371F-44F0-9146-64717F979544 Q37459239-4047DD19-6815-4BA0-97A5-F28B1B914855 Q37459352-C1345BBF-7083-46C7-9D20-C529E7BFD16A Q37475020-8420ADB2-A5AF-4817-99EE-F9D7339A4957 Q37696203-CEE5FF44-7A5F-47AA-9856-E037D61BCF00 Q37703388-C5F186ED-E673-4B77-9BF7-7F2574541675 Q37800949-06E530A1-E2C4-44B7-B310-2E54428C91DA Q37953476-28BD2DCA-D27C-432D-ABFB-E9A655016B4C Q37980054-ED74D603-43DB-47EA-A5DC-8979EB51B5A7 Q38019157-25AD78FE-1B9C-48C4-B3BA-1412E054FD88 Q38388694-595FBB40-9164-4D61-80A3-6F466DB7A69E Q39420117-B7C71E6D-27E7-4BEC-A475-7A3864E4DD0A

P2860

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

http://www.wikidata.org/entity/Q33341180

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Involvement of TSC genes and d ...... oral squamous cell carcinoma.

@ast

Involvement of TSC genes and d ...... oral squamous cell carcinoma.

@en

type

label

Involvement of TSC genes and d ...... oral squamous cell carcinoma.

@ast

Involvement of TSC genes and d ...... oral squamous cell carcinoma.

@en

prefLabel

Involvement of TSC genes and d ...... oral squamous cell carcinoma.

@ast

Involvement of TSC genes and d ...... oral squamous cell carcinoma.

@en

P1433

Q33341180-D0D58407-52E2-48E9-9FD7-E5067011844F

P1476

Q33341180-B9EFE7FF-4A74-4AA2-8587-78A5238D7D7E

P2093

Q33341180-2A219E81-88F1-4988-B1BF-6B11715D626C

Q33341180-8648C77E-94D9-4244-8AF6-293C34C4F90C

Q33341180-DAFA38E2-418A-4499-BD47-487C07D3DB2F

Q33341180-DE6A19CD-F20D-4F80-9D65-E3470243A575

P2860

Q33341180-0765EF8A-B78A-4555-8C51-290CA9F636A9

Q33341180-0B4DC3E1-4660-4770-8786-E717F9153087

Q33341180-0D6AD9B3-CD25-497C-B9C2-88C738383F39

Q33341180-14EA16C1-738F-4F46-972E-5BD4015D0186

Q33341180-240918C8-C2D3-42D7-BDD1-F18B997C3F49

Q33341180-2467A465-3CAF-418F-A671-71EEA608993D

Q33341180-25A367D0-26D7-4B51-875A-D27F59AB2C94

Q33341180-26D49B1C-C9E3-4CE8-84ED-2B1CDB2EDC81

Q33341180-28F94DE2-C9D5-4499-AAD4-7227E88617E5

Q33341180-51C8EFE9-1359-4EC5-89FA-E866B172924B

P2888

Q33341180-DD76259B-EAEF-47BC-9962-A5ACE642FC64

P304

Q33341180-69D9D02E-12D4-4709-9988-5F48D7ABDE3A

P31

Q33341180-34F2AE7C-4D0F-48E5-9295-070B749BF35B

P356

Q33341180-EB846DDD-EFD6-420E-A979-D72A7942C0DA

P407

Q33341180-7051E139-7F73-4BD9-8879-5DE28506F6C8

P478

Q33341180-6528DD39-BD8D-4DCE-B052-9740563CBE7F

P577

Q33341180-3B413E22-CEE1-4E85-82A3-7EE312CCBD77

P5875

Q33341180-84E804F6-B235-4221-BF39-C8DBA6147437

P6179

Q33341180-55F7AC57-DFA7-454C-8622-80D63C94EFAE

P698

Q33341180-146CBFFB-1B67-40E8-B2D3-E5EAE0C2534B

P932

Q33341180-E1AD4752-6077-4A2A-8B27-CEC0661BA489

P356

1471-2407-8-163

P1433

P1476

Involvement of TSC genes and d ...... oral squamous cell carcinoma.

@en

P2093

Arun Kumar

http://www.w3.org/2001/XMLSchema#string

K S Gopinath

http://www.w3.org/2001/XMLSchema#string

S M Azeem Mohiyuddin

http://www.w3.org/2001/XMLSchema#string

Sanjukta Chakraborty

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers

Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction

MethPrimer: designing primers for methylation PCRs

Over-expression of 14-3-3zeta is an early event in oral cancer.

eIF4E expression in tumors: its possible role in progression of malignancies.

The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.

The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.

The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.

P2888

1471-2407-8-163

P304

163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-163

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5319579

http://www.w3.org/2001/XMLSchema#string

P6179

1003945379

http://www.w3.org/2001/XMLSchema#string

P698

18538015

http://www.w3.org/2001/XMLSchema#string

P932

2430211

http://www.w3.org/2001/XMLSchema#string